Patients with LVV and IBD present with distinct clinical characteristics, including earlier onset and more severe vascular involvement.

SUNRISE-PD evaluating the Company’s anti-inflammatory, insulin-sensitizing candidate bezisterim in patients with Parkinson’s disease who have not ...

An AI-based algorithm may help detect chronic liver disease using images from standard echocardiography, according to study ...

Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin-3 for patients with MASH cirrhosis and portal hypertension, today announced that it will attend the ...

Learn how nonalcoholic fatty liver disease develops, its warning signs, and the steps to help safeguard the liver.

Eating a diet high in red and processed meats puts you at greater risk for non-alcoholic fatty liver disease. These foods are ...

Women experiencing menopause are more likely to develop MASH, a severe form of nonalcoholic fatty liver disease, than men of the same age.

Cirrhosis is the 10th leading cause of death in the US and causes nearly 55,000 deaths per year. Common symptoms of a ...

Discover how Akero Therapeutics' EFX outshines competitors in MASH treatment, with groundbreaking results and strong ...

and Pfizer-Canada Inc. Dr. Yoshida has also disclosed that he has been an investigator on clinical studies/trials sponsored by Hoffman-LaRoche - Canada, Schering - Canada, Fujisawa - Canada ...

It’s a worrying time for many people and we want to be there for you whenever - and wherever - you need us. Cancer Chat is our fully moderated forum where you can talk to others affected by cancer, ...

A person with liver disease symptoms should consult a doctor to determine the best treatment. Early treatment can often stop or slow the progression of liver disease and improve a person’s ...